| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 691489 | 09599006 | RIVASTIGMINA SANDOZ 3 mg CAPSULAS DURAS EFG | RIVASTIGMINA SANDOZ 3 mg CAPSULAS DURAS EFG, 56 cápsulas | 3 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09599006/09599006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09599006/09599006_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 0 | 2012-08-10 | View Edit Delete | ||||||||||||
| 691490 | 09599015 | RIVASTIGMINA SANDOZ 6 mg CAPSULAS DURAS EFG | RIVASTIGMINA SANDOZ 6 mg CAPSULAS DURAS EFG, 112 cápsulas | 6 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09599015/09599015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09599015/09599015_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 0 | 2012-08-10 | View Edit Delete | ||||||||||||
| 691549 | 09599010 | RIVASTIGMINA SANDOZ 4,5 mg CAPSULAS DURAS EFG | RIVASTIGMINA SANDOZ 4,5 mg CAPSULAS DURAS EFG, 56 cápsulas | 4,5 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09599010/09599010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09599010/09599010_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2012-06-21 | 1 | 1 | 1 | 2012-06-21 | 2012-06-21 | 0 | 2012-08-10 | View Edit Delete | ||||||||||||
| 691551 | 09599011 | RIVASTIGMINA SANDOZ 4,5 MG CAPSULAS DURAS EFG | RIVASTIGMINA SANDOZ 4,5 MG CAPSULAS DURAS EFG , 112 cápsulas | 4,5 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09599011/09599011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09599011/09599011_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2012-06-21 | 1 | 1 | 1 | 2012-06-21 | 2012-06-21 | 0 | 2012-08-10 | View Edit Delete | ||||||||||||
| 691552 | 09599014 | RIVASTIGMINA SANDOZ 6 mg CAPSULAS DURAS EFG | RIVASTIGMINA SANDOZ 6 mg CAPSULAS DURAS EFG, 56 cápsulas | 6 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09599014/09599014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09599014/09599014_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2012-06-21 | 1 | 1 | 1 | 2012-06-21 | 2012-06-21 | 0 | 2012-08-10 | View Edit Delete | ||||||||||||
| 693348 | 76533 | ATORVASTATINA SUN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA SUN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76533/76533_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76533/76533_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2012-09-27 | 1 | 1 | 1 | 2012-09-27 | 2012-09-27 | 1 | 2013-06-17 | View Edit Delete | ||||||||||||
| 693349 | 76534 | ATORVASTATINA SUN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA SUN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76534/76534_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76534/76534_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2012-09-27 | 1 | 1 | 1 | 2012-09-27 | 2012-09-27 | 1 | 2013-07-04 | View Edit Delete | ||||||||||||
| 693350 | 76535 | ATORVASTATINA SUN 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA SUN 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76535/76535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76535/76535_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2012-09-27 | 1 | 1 | 1 | 2012-09-27 | 2012-09-27 | 1 | 2013-06-17 | View Edit Delete | ||||||||||||
| 693351 | 76536 | ATORVASTATINA SUN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA SUN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76536/76536_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76536/76536_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2012-09-27 | 1 | 1 | 1 | 2012-09-27 | 2012-09-27 | 1 | 2013-06-17 | View Edit Delete | ||||||||||||
| 693651 | 76603 | VENLAFAXINA SUN 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA | VENLAFAXINA SUN 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 150 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76603/76603_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76603/76603_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2012-10-08 | 1 | 1 | 1 | 2021-01-12 | 2021-01-12 | 1 | 2018-04-12 | View Edit Delete | ||||||||||||
| 693661 | 76604 | VENLAFAXINA SUN 75 MG COMPRIMIDOS DE LIBERACION PROLONGADA | VENLAFAXINA SUN 75 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 75 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76604/76604_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76604/76604_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2012-10-08 | 1 | 1 | 1 | 2017-07-06 | 2017-07-06 | 1 | 2018-04-12 | View Edit Delete | ||||||||||||
| 692020 | 59069 | ZOFRAN 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZOFRAN 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 6 comprimidos | 4 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59069/59069_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59069/59069_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 1991-06-01 | 1 | 1 | 1 | 1991-06-01 | 1994-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 692038 | 59069 | ZOFRAN 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZOFRAN 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 15 comprimidos | 4 mg | 5 | 15 | 10 | 15 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59069/59069_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59069/59069_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 1991-06-01 | 1 | 1 | 1 | 1991-06-01 | 1994-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 692046 | 59070 | ZOFRAN 8 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZOFRAN 8 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 6 comprimidos | 8 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59070/59070_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59070/59070_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 1991-06-01 | 1 | 1 | 1 | 1991-06-01 | 1994-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 692053 | 59070 | ZOFRAN 8 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZOFRAN 8 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 15 comprimidos | 8 mg | 5 | 15 | 10 | 15 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59070/59070_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59070/59070_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 1991-06-01 | 1 | 1 | 1 | 1991-06-01 | 1994-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 691358 | 76060 | EQUASYM 30 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | EQUASYM 30 mg CAPSULAS DURAS DE LIBERACION MODIFICADA, 30 cápsulas | 30 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76060/76060_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76060/76060_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2012-06-12 | 1 | 1 | 1 | 2012-06-12 | 2012-06-12 | 1 | 2013-02-26 | Lista II | View Edit Delete | |||||||||||
| 691449 | 76076 | EQUASYM 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | EQUASYM 20 mg CAPSULAS DURAS DE LIBERACION MODIFICADA, 30 cápsulas | 20 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76076/76076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76076/76076_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2012-06-15 | 1 | 1 | 1 | 2012-06-15 | 2012-06-15 | 1 | 2013-02-26 | Lista II | View Edit Delete | |||||||||||
| 692389 | 76267 | RIVASTIGMINA VIR 1.5 MG CAPSULAS DURAS EFG | RIVASTIGMINA VIR 1.5 MG CAPSULAS DURAS EFG , 112 cápsulas | 1,5 mg | 5 | 112 | 43 | 112 capsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76267/76267_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76267/76267_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2013-11-08 | 1 | 1 | 1 | 2013-11-08 | 2013-11-18 | 0 | 2015-06-26 | View Edit Delete | ||||||||||||
| 694318 | 76709 | OLANZAPINA VIR 5 MG COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA VIR 5 MG COMPRIMIDOS BUCODISPERSABLES EFG , 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76709/76709_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76709/76709_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2012-10-30 | 1 | 1 | 1 | 2012-10-30 | 2012-10-30 | 1 | 2025-07-10 | View Edit Delete | ||||||||||||
| 694319 | 76710 | OLANZAPINA VIR 10 MG COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA VIR 10 MG COMPRIMIDOS BUCODISPERSABLES EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76710/76710_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76710/76710_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2012-10-30 | 1 | 1 | 1 | 2012-10-30 | 2012-10-30 | 1 | 2021-04-26 | View Edit Delete |
Page 291 of 1036, showing 20 records out of 20704 total, starting on record 5801, ending on 5820